1. Clinical Overview
Bethanechol chloride is a synthetic parasympathomimetic choline ester that acts as a direct muscarinic receptor agonist. It is a quaternary ammonium compound that does not cross the blood-brain barrier. It is primarily used to stimulate smooth muscle contraction in the urinary bladder and gastrointestinal tract, particularly in conditions of atony or postoperative/postpartum retention. It is resistant to hydrolysis by acetylcholinesterase, leading to a longer duration of action than acetylcholine.
| Onset | Duration | Bioavailability |
|---|---|---|
| Oral: 30 to 90 minutes. Subcutaneous: 5 to 15 minutes. | Oral: Approximately 1 to 6 hours. Subcutaneous: Approximately 2 hours. | Poor and variable (estimated <5%) due to its quaternary ammonium structure limiting absorption from the GI tract. |
2. Mechanism of Action
Bethanechol directly binds to and activates muscarinic acetylcholine receptors (primarily M2 and M3 subtypes) on postganglionic parasympathetic effector cells. This activation mimics the action of acetylcholine, leading to increased tone and motility of smooth muscle in the urinary bladder detrusor and gastrointestinal tract. It also stimulates secretion from exocrine glands.
3. Indications & Uses
- Acute postoperative and postpartum non-obstructive urinary retention
- Neurogenic atony of the urinary bladder with retention (e.g., due to diabetic cystopathy, spinal cord injury)
4. Dosage & Administration
Adult Dosage: Oral: Initial: 10-25 mg three to four times daily. Usual range: 25-50 mg three to four times daily. Maximum single dose: 50 mg. Subcutaneous: 2.5 to 5 mg, may be repeated in 15-30 minutes if necessary (rarely used).
Administration: Administer on an empty stomach (1 hour before or 2 hours after meals) to reduce nausea and abdominal cramping. For urinary retention, the dose should be timed so that the peak effect (1-2 hours post-dose) coincides with an attempt to void. Do not crush or chew tablets. Subcutaneous administration is reserved for hospital settings.
5. Side Effects
Common side effects may include:
- Abdominal cramps or discomfort
- Diarrhea
- Nausea and vomiting
- Salivation
- Flushing (cutaneous vasodilation)
- Sweating
- Headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Cholinergic Agents (e.g., Pilocarpine, Donepezil, Rivastigmine) | Additive cholinergic effects, increased risk of toxicity. | Major |
| Anticholinergic Agents (e.g., Atropine, Oxybutynin, Tricyclic Antidepressants, Antipsychotics, Antihistamines) | Pharmacological antagonism; reduces therapeutic effect of Bethanechol. | Major |
| Beta-blockers (e.g., Propranolol) | Additive bradycardia. | Moderate |
| Quinidine, Procainamide | May antagonize cholinergic effects. | Moderate |
| Cholinesterase Inhibitors (e.g., Neostigmine, Pyridostigmine) | Additive cholinergic effects. | Major |
| Ganglionic Blocking Agents (e.g., Trimethaphan) | May cause severe hypotension. | Major |
7. Patient Counselling
- Do take the medication on an empty stomach (1 hour before or 2 hours after food).
- Do try to urinate about 1 hour after taking the dose for urinary retention.
- Do inform all your doctors and dentists you are taking this medicine.
- Do not take if you have a fever, asthma attack, or recent GI/urinary surgery without consulting your doctor.
- Do not crush or chew the tablet.
8. Toxicology & Storage
Overdose: Symptoms of cholinergic crisis: Severe nausea, vomiting, abdominal cramps, diarrhea, salivation, sweating, lacrimation, miosis, bradycardia, hypotension, bronchospasm, involuntary defecation and urination, cardiac arrest, and shock. Muscle weakness and respiratory paralysis can occur.
Storage: Store at controlled room temperature (15-25°C). Protect from light and moisture. Keep out of reach of children.